[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"recurrent-pancreatitis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:recurrent-pancreatitis":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,42],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100543923","vr-pilot-for-pancreatitis-100543923",false,"NCT06362187","VR Pilot for Pancreatitis","A Feasibility Study on Gut-Directed Virtual Reality for Chronic Pain Related to Chronic Pancreatitis","Inclusion Criteria:\n\n* Diagnosis of CP \\[as determined by Cambridge 3-4 imaging classification (using CT, MRI, or MRCP) or a histologic diagnosis of CP\\]\n* Clinically significant abdominal pain, measured using the standardized NIH PROMIS GI Pain Scale14 and defined as scoring at least 5 points above the nationally normed score (0.5 SD effect size), indicating equal or greater than the minimally clinically important difference (MCID) of abdominal pain\n* Are 18-75 years of age\n* Are able to read\u002Fwrite English. The study does not include non-English speakers as to current study material are only available in English.\n\nExclusion Criteria:\n\n* Patients who are presenting with a condition that interferes with VR usage (e.g., seizures, facial injury precluding safe placement of headset, visual impairment)\n* Patients who have cognitive impairment that affects protocol participation\n* Patients who are recommended for long-term hospitalization\n* Patients who are estimated to live \\\u003C3 months from the time of enrollment\n* Patients who have been diagnosed with a pancreatic tumor\n* Patients who have been enrolled in an interventional\u002Ftherapeutic drug trial for chronic or recurrent pancreatitis within the last 6 months","ALL","18 Years","75 Years",{"count":20,"type":21},20,"ESTIMATED","INTERVENTIONAL",[24],"NA","The purpose of the research is to test the feasibility and preliminary impact of a home-based, standardized, gut-directed, virtual reality cognitive behavioral therapy (VR CBT) on clinical and functional outcomes of patients with chronic pancreatitis (CP) pain. The primary research procedures are questionnaires and biometric Fitbit data. The study will enroll adult patients with CP.",[27,28],"Chronic Pancreatitis","Recurrent Pancreatitis","NOT_YET_RECRUITING","2026-02-21",{"date":32,"type":33},"2026-02-24","ACTUAL",{"date":35,"type":21},"2026-07-22",{"date":37,"type":21},"2028-05",{"name":39,"class":40},"Cedars-Sinai Medical Center","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":4,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":69},"100351255","fibro-inflammatory-progression-from-acute-to-chronic-pancreatitis-100351255","NCT03853447","Fibro-inflammatory Progression From Acute to Chronic Pancreatitis","Characterization of Fibro-inflammation During Progression From Acute to Chronic Pancreatitis","Inclusion Criteria:\n\n* Patients with CP (N=50) of any aetiology except gallstone induced CP: CP will be diagnosed based on MANNHEIM criteria .\n* Cohort 2: Patients with their first attack of AP of any aetiology except gallstone induced AP (N=50). The revised Atlanta criteria for acute pancreatitis will be used as diagnostic criteria.\n* Cohort 3: Patients with RAP (N=50) except gallstone induced RAP. RAP is defined as two or more cases of AP as diagnosed by the revised Atlanta Criteria.\n\nExclusion Criteria:","70 Years",{"count":51,"type":21},150,"OBSERVATIONAL","Observational prospective study evaluating the developement of chronic pancreatitis based on imaging modalities as well as biochemical markers of inflammation, fibrosis and oxidative stress.",[55,56,28,27,57,58],"Pancreatitis","Acute Pancreatitis","Inflammation","Fibrosis","RECRUITING","2020-04-07",{"date":62,"type":33},"2020-04-08",{"date":64,"type":33},"2019-02-14",{"date":66,"type":21},"2041-01-01",{"name":68,"class":40},"Copenhagen University Hospital, Hvidovre",3]